Phase I Study Of The Antibody-Drug Conjugate Brentuximab Vedotin Combined With Re-Induction Chemotherapy In Patients With Cd30-Expressing Relapsed/Refractory Acute Myeloid LeukemiaAmir T. Fathi,Traci M. Blonquist,Ashkan Emadi,Andrew M. Brunner,Gabriela S. Hobbs,Hanno Hock,Steven L. Mcafee,Robert P. Hasserjian,Frederic I. Preffer,Jenna A. Moran,Meghan Bergeron,Julia Foster,Christina Bertoli,Kristin Mcgregor,Kaitlyn Fishman,Molly Macrae,Meghan Burke,Tanya T. Behnan,Tina T. Som,Aura Y. Ramos,Megan K. Vartanian,Jennifer Lombardi Story,Patricia Lesho,Vu H. Duong,Mason Mann,Christopher Lescinskas,Christine Connolly,Donna S. Neuberg,Karen K. Ballen,Philip C. AmreinBLOOD(2018)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要